These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17995974)

  • 21. The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development.
    Smith JM; Flexner C
    AIDS; 2017 Jun; 31 Suppl 2():S173-S184. PubMed ID: 28471948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and drug-drug interactions of antiretrovirals: an update.
    Dickinson L; Khoo S; Back D
    Antiviral Res; 2010 Jan; 85(1):176-89. PubMed ID: 19665485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between antifungal and antiretroviral agents.
    Hughes CA; Foisy M; Tseng A
    Expert Opin Drug Saf; 2010 Sep; 9(5):723-42. PubMed ID: 20345324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is it time to revise antiretrovirals dosing? a pharmacokinetic viewpoint.
    Cattaneo D; Baldelli S; Castoldi S; Charbe N; Cozzi V; Fucile S; Clementi E
    AIDS; 2014 Oct; 28(16):2477-80. PubMed ID: 25392858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Authors' reply: pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives.
    Nwokolo N; Boffito M
    Clin Pharmacokinet; 2015 May; 54(5):565. PubMed ID: 25732266
    [No Abstract]   [Full Text] [Related]  

  • 26. Emerging antiretroviral drug interactions.
    Pham PA; Flexner C
    J Antimicrob Chemother; 2011 Feb; 66(2):235-9. PubMed ID: 21131695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Incidence and Severity of Drug Interactions Before and After Antiretroviral Therapy Simplification in Treatment-Experienced Patients With HIV Infection.
    Hastain NV; Santana A; Schafer JJ
    Ann Pharmacother; 2020 Jan; 54(1):36-42. PubMed ID: 31364373
    [No Abstract]   [Full Text] [Related]  

  • 28. Dosing antiretroviral medication when crossing time zones: a review.
    Lewis JM; Volny-Anne A; Waitt C; Boffito M; Khoo S
    AIDS; 2016 Jan; 30(2):267-71. PubMed ID: 26684823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-daily therapies.
    Carey D
    J HIV Ther; 2003 Feb; 8(1):7-11. PubMed ID: 12840708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herbal remedies in resource-poor settings: friend or foe?
    Dooley KE; Flexner C; Andrade AS
    Clin Pharmacol Ther; 2008 Jul; 84(1):23. PubMed ID: 18253144
    [No Abstract]   [Full Text] [Related]  

  • 31. How relevant are the drug-drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life?
    Cattaneo D; Formenti T; Astuti N; Meraviglia P; Ridolfo A; Gervasoni C
    J Antimicrob Chemother; 2018 Aug; 73(8):2271-2273. PubMed ID: 29897531
    [No Abstract]   [Full Text] [Related]  

  • 32. Managing Pharmacotherapy in People Living With HIV and Concomitant Malignancy.
    Olin JL; Klibanov O; Chan A; Spooner LM
    Ann Pharmacother; 2019 Aug; 53(8):812-832. PubMed ID: 30770025
    [No Abstract]   [Full Text] [Related]  

  • 33. Editorial commentary: cerebrospinal fluid inhibitory quotients of antiretroviral drugs.
    Fletcher CV
    Clin Infect Dis; 2015 Jan; 60(2):318-20. PubMed ID: 25281611
    [No Abstract]   [Full Text] [Related]  

  • 34. INFECTIOUS DISEASE. Researchers claim to find HIV sanctuaries.
    Cohen J
    Science; 2016 Jan; 351(6272):434. PubMed ID: 26823407
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiretroviral drug concentrations in the male and female genital tract: implications for the sexual transmission of HIV.
    Taylor S; Davies S
    Curr Opin HIV AIDS; 2010 Jul; 5(4):335-43. PubMed ID: 20543610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug interactions between proton pump inhibitors and antiretroviral drugs.
    McCabe SM; Smith PF; Ma Q; Morse GD
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):197-207. PubMed ID: 17428151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simplification of antiretroviral therapy with etravirine.
    Martínez E; Nelson M
    AIDS Rev; 2010; 12(1):52-9. PubMed ID: 20216910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV therapy--what do we know, and when do we know it?
    Skolnik PR
    N Engl J Med; 2003 Dec; 349(24):2351-2. PubMed ID: 14668462
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders.
    Milazzo L; Cattaneo D; Calvi E; Gervasoni C; Mazzali C; Ronzi P; Peri AM; Ridolfo AL; D'Avolio A; Antinori S
    Int J Antimicrob Agents; 2015 May; 45(5):545-9. PubMed ID: 25769784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.
    Wu H; Huang Y; Acosta EP; Park JG; Yu S; Rosenkranz SL; Kuritzkes DR; Eron JJ; Perelson AS; Gerber JG
    J Pharmacokinet Pharmacodyn; 2006 Aug; 33(4):399-419. PubMed ID: 16583266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.